|

Lamivudine Clinical Trials

2 actively recruiting trials across 2 locations

Also known as: (-)-BCH-189, 3TC, Epivir, GR109714X, LAM

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • University of Miami1
  • Roswell Park Cancer Institute1

Indications

  • Cancer2
  • Extensive Stage Lung Small Cell Carcinoma1
  • High Grade Glioma1
  • Lung Cancer1

Miami, Florida1 trial

STARLITE for Unresectable High-Grade Gliomas

University of Miami

Phase 1

Buffalo, New York1 trial

Lamivudine in Combination With Chemoimmunotherapy for the Treatment of Extensive Stage Small Cell Lung Cancer

Roswell Park Cancer Institute

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.